In blood vessels and in artificial tubes with diameters of less than 500 p m blood viscosity d e c r e a s e s with decreasing tube diameter (FahraeusLindqvist effect). For RBC-buffer suspensions lhis effect is stronger for neonatal than for adult RBC. (Pediatr.Res.25:595,1989) In the present investigation we studied the effect of autologous plasma, adult plasma and serum on the viscosity of RBC from 1 0 adults, 1 0 term and 1 0 preterm infants.
CONTRIBUTIONS OF PLASMA. SERUM AND RED BLOOD CELLS ( RBC ) TO VICOSITY REDUCTION OF BLOOD FROM TERM AND PRETERM INFANTS STUDIED IN NARROW TUBES
35 Eugen P. Zilow, Sabine Born a n d Otwin Linderkamp -Department of Pediatrics. University of Heidelberg, D-6900 Heidelberg. Germany In blood vessels and in artificial tubes with diameters of less than 500 p m blood viscosity d e c r e a s e s with decreasing tube diameter (FahraeusLindqvist effect). For RBC-buffer suspensions lhis effect is stronger for neonatal than for adult RBC. (Pediatr.Res.25:595,1989) In the present investigation we studied the effect of autologous plasma, adult plasma and serum on the viscosity of RBC from 1 0 adults, 1 0 term and 1 0 preterm infants.
T h e hematocrits of the samples were adjusted a: 20. 40 a n d 6 0 %. Glass tubes with diameters of 270. 100 a n d 5 5 p m were perfused with these suspensions.The lable shows the viscosity reductions for RBC suspensions with a hematocrit of 6 0 % w h e n going from 270 to 5 5 pm tubes. At a given feed hematocrit there w a s n o difference in viscosity reduction among the suspension media in the three a g e groups. W e conclude that differences in Fahraeus-Linqvist effect among adults, terrn and preterm neonates a r e d u e to specific properties of RBC and independent of plasma properties.
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Polycythaemia i n newborn i n f a n t s may l e a d t o a v a r i e t y o f c l i n i c a l symptoms, probably a s a r e s u l t of impaired blood flow. Besides h a e m a t o c r i t ( H c t ) , plasma v i s c o s i t y (PV) is an important d e t e r m i n a n t f o r blood v i s c o s i t y . We s t u d i e d PV i n 46 polycythaemic (mean Hct 72%, range 65-80) newborn i n f a n t s . F i f t e e n were pceterm, 1 2 s m a l l f o r g e s t a t i o n a l age (SGA), and 1 9 a p p r o p r i a t e f o r g e s t a t i o n a l a g e (AGA). A c o n t r o l group (mean Hct 58%. range 52-64) c o n s i s t e d o f 42 newborn i n f a n t s . PV was measured u s i n g a c a p i l l a r y t u b e viscometer. Polycythaemic i n f a n t s had a s i g n i f i c a n t l y ( p c 0.05) lower PV l e v e l (1.060 ( r a n g e 0.950-1.230)m Pa.sl than c o n t r o l i n f a n t s 11.120 ( r a n g e 0.960-1.540)m P a . s l . Preterm polycythaemic and c o n t r o l i n f a n t s had s i g n i f i c a n t l y lower PV l e v e l s t h a n SGA and AGA polycythaemic and c o n t r o l i n f a n t s . T h i r t yt h r e e (71.7%) polycythaemic i n f a n t s had c l i n i c a l symptoms. The PV l e v e l i n t h e group w i t h c l i n i c a l symptoms was s i g n i f i c a n t l y ( p c 0.05) h i g h e r 11.067 ( r a n g e 0.985-1.230)m P a . s l than i n t h e group without c l i n i c a l symptoms 11.013 (range 0.950-1.183lm Pa.sl. We conclude t h a t 1) PV i n polycythaemic newborn i n f a n t s is lower t h a n i n c o n t r o l i n f a n t s , and 2 ) c l i n i c a l symptoms seem t o be a s s o c i a t e d w i t h a combination of polycythaemia and higher PV.
ATRIAL NATRIURETIC PEPTIDE (ANP), RENAL FUNC-TION, AND PDA I N PRETERM INFANTS
37 ' H e n r i k E k b l a d , ' p e n t t i K e r o , ' o l l i V u o lt e e n a h o , ' 0 l l i A r j a m a a , ' H e i k k i K o r v e n r a n t a a n d ' S t a n l e y G. S h a f f e r , s p n . b y ' 1 l k k a V a l im a k i -'~e p a r t m e n t o f P e d i a t r i c s , U n i v e r s i t y o f T u r k u , S F -2 0 5 2 0 T u r k u , F i n l a n d , 2~e p a r t m e n t o f P h y s i o l o g y , U n i v e r s i t y o f O u l u , O u l u , F i n l a n d a n d '~e r i n a t a l P e d ia t r i c s , S t . L u k e ' s H o s p i t a l , U n i v e r s i t y o f M i s s o u r i S c h o o l o f M e d i c i n e , K a n s a s C i t y , MO, U . S . A . I n t h e n e o n a t e , t h e r o l e o f ANP i n t h e r e g u l a t i o n o f f l u i d b a l a n c e i s n o t c l e a r . We a s s e s s e d t h e r e l a t i o n o f ANP i n p r e t e r m i n f a n t s t o r e n a l f u n c t i o n a n d PDA o n d a y s 2 a n d 5 . P-ANP w a s m e a s u r e d b y RIA; G 1 ( < 3 0 wk, n = 1 1 ) a n d G2 ( 3 0 -3 4 wk, n = 1 2 ) . PDA w a s a s s e s s e d o n d a y 2 . P-ANP w a s h i g h e r i n G 1 t h a n i n G2 ( p C 0 . 0 1 ) a n d d e c r e a s e d b y d a y 5 ( p < 0 . 0 2 ) . A n e g a t i v e c o r r e l a t i o n b e t w e e n P-ANP a n d GA w a s f o u n d ( d a y 2 : r = -0 . 5 4 , p < 0 . 0 1 : d a y 5 : r = -0 . 4 5 , p < 0 . 0 5 ) . No c o r r e l a t i o n b e t w e e n P-ANP a n d CCr o r U V w a s f o u n d . I n f a n t s w i t h PDA h a d h i g h e r P-ANP t h a n ' i n f a n t s w i t h o u t PDA i n G 1 ( p < 0 . 0 2 ) , b u t n o t i n G2. P r e t e r m i n f a n t s are a b l e t o release h u g e a m o u n t s o f ANP p o s t n a t a l l y . T h e h i g h P-ANP c o nc e n t r a t i o n s s e e n p o s t n a t a l l y d o n o t d i r e c t l y c o r r e l a t e t o t h e r e n a l r e g u l a t i o n o f s o d i u m a n d w a t e r b a l a n c e . A -a D 0 2 was 643 mmHg (596-658) and all received domapine. PC (10-200 ng/kg/min) was started at a mean age of 28.6 hr (range 2.8-87). Oxygenation improved usually within minutes. Mean duration of PC was 3.4 days, and exiubation age 8 days (1.8-16).
The main side effect was hypotension, easily conrrolled by pressors. Four children died at 1-3 days of age (2 asphyxia, 1 pneumothorax, I pneumonia). Only 3 of the 2 6 surviving infants had minor neurological o r pulmonary sequcl;te. Prostacycline should be considered as an alternative to EChlO in severe Ptl. In the l;.sl few years we haw been able to produce a large bod? of evidences that ARA.C is capable of inducing neuronal d~lferenliation of human neuroblasts in vitro. Three different human ncurohlastoma (NB) ccll lines haw been leslrd with ARA-C. LAN-I. LAN-? and (;I-ME-%. AKA-C actuall! modifies both surface and cytoskelelon markers' expression ~h i l c inducing substained morphologic differcniia~ion of all three NB ccll lines. Spccificall!. ARA-C induces concentraiion-dependent grourh inhibition. ncuritc sprouling. and ncurofilamer.tr expression in GI-ME-Y cclls. \,hilt decreasing the le\el of mcmhranc an1igcn5 specific for ncuroblast cells.The maximum effecl was ohiaincd using a dose as lo\vasO.I nigrnl. S!niilar modifications were recorded inducing both LAN-1 and LAN.5 human NB cells vilh A R A C The lac1 ~hai ARA.C treatment of human NB cells started one day afler pla~ingui~h no suhscqueni decrease in ccll \iabilitv in the cultures, s~rongly sugpcats that ils cffccts were no1 ~h c result of selcclion ol more diflerenti31cd cells by differences in plating effiricnc! or AKA-C cytotoxicily. This conclusion wa5 supported by time-lapse phototnycroscopic observations, which clearl? shou.ed ~ndi\.idual ARA-C ~rcaled N B cclls undergoing n~orphologic differentiation. The rrsults rise the suspicious that the interpretation of ARA-C mechanism5 of aclion on PI') carctnoe~nbrional cclls is o~~crscmplici~tic. We actuall? do no1 ihing that "...one can sclectivcly enrich for neurons by-Ircaiing the induced cullure ~i l h the anti'mctabol!ic AKA-C" as suggested b! Chung JJM el al (Cell (A. LX' )-Z(M. L1)91). In fact. as prc!iousl) dcmonslrated h) our group, ARA-C is not onl! capable of arrerl the o\crgru\ring of non-ncuronal cells. but is arli\cl! capable of pushing ncuroblas~ cclls along thc ncurrmdl rlifferentiation palhuay
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